Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001157523-23-000832
Filing Date
2023-05-12
Accepted
2023-05-12 16:15:32
Documents
12
Period of Report
2023-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K/A a53399029.htm   iXBRL 8-K/A 24954
  Complete submission text file 0001157523-23-000832.txt   159927

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA usna-20230510.xsd EX-101.SCH 3916
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20230510_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20230510_pre.xml EX-101.PRE 16038
6 EXTRACTED XBRL INSTANCE DOCUMENT a53399029_htm.xml XML 4082
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35024 | Film No.: 23915900
SIC: 2833 Medicinal Chemicals & Botanical Products